|
| Press Releases |
|
 |
|
| Thursday, March 20, 2025 |
|
|
亨得利2024全年收入錄得人民幣10.44億元 |
| 亨得利控股有限公司（「亨得利」或「公司」及其子公司「集團」，股票編號：3389）宣佈截至2024年12月31日止12個月（「回顧年內」）之全年業績。 more info >> |
|
|
Hengdeli's revenue for 2024 recorded RMB1.04 Billion |
| Hengdeli Holdings Limited ("Hengdeli" or the "Company" and, together with its subsidiaries, the "Group"; stock code: 3389) announced its annual results for the twelve months ended 31 December 2024 ("the year under review"). more info >> |
|
亨得利2024全年收入录得人民币10.44亿元
|
| 亨得利控股有限公司（「亨得利」或「公司」及其子公司「集团」，股票编号：3389）宣布截至2024年12月31日止12个月（「回顾年内」）之全年业绩。 more info >> |
|
| Wednesday, August 21, 2024 |
|
|
Hengdeli Announces 2024 Interim Results Sound, Steady, and Long-Term Operations |
| Hengdeli Holdings Limited ('Hengdeli' or the 'Company' and, together with its subsidiaries, the 'Group'; stock code: 3389) announced its interim results for the six months ended 30 June 2024 (" the period under review"). more info >> |
|
|
亨得利2024年中期业绩发布 行稳致远 持续经营 |
| 亨得利控股有限公司（「亨得利」或「公司」及其子公司「集团」，股票代号：3389）宣布截至2024年6月30日止6个月（「回顾期内」）之中期业绩。 more info >> |
|
|
亨得利2024年中期業績發佈 行穩致遠 持續經營 |
| 亨得利控股有限公司（「亨得利」或「公司」及其子公司「集團」，股票代號：3389）宣佈截至2024年6月30日止6個月（「回顧期內」）之中期業績。 more info >> |
|
| Wednesday, March 20, 2024 |
|
|
亨得利公布2023全年业绩发布 |
亨得利控股有限公司（「亨得利」或「公司」及其子公司「集团」，股票编号：3389）宣布截至2023年12月31日止12个月（「回顾年内」）之全年业绩。
more info >> |
|
|
亨得利公佈2023全年業績發佈 |
| 亨得利控股有限公司（「亨得利」或「公司」及其子公司「集團」，股票編號：3389）宣佈截至2023年12月31日止12個月（「回顧年內」）之全年業績。 more info >> |
|
|
Hengdeli Announces 2023 Annual Results |
Hengdeli Holdings Limited ("Hengdeli" or the "Company" and, together with its subsidiaries, the "Group"; stock code: 3389) announced its annual results for the twelve months ended 31 December 2023 ("the year under review").
more info >> |
|
| Tuesday, August 22, 2023 |
|
|
Hengdeli narrowed its loss by 91.3% in 1H2023 |
| Hengdeli Holdings Limited (3389) announced its interim results for the six months ended 30 June 2023. During the period under review, the Group recorded revenue of RMB675,621,000, representing a year-on-year increase of 20.9% more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Kangji Medical Receives Privatisation Proposal from a Consortium Led by Kangji Medical's Chairman, Zhong Ming, TPG and QIA to Advance Long-Term Strategic Vision
Aug 13, 2025 23:21 HKT/SGT
|
|
|
GEON Performance Solutions Achieves Great Place to Work Recognition Globally Second Year in a Row
Aug 13, 2025 23:18 HKT/SGT
|
|
|
AI Inference vs. AI Training: What Are the Differences?
Aug 13, 2025 23:03 HKT/SGT
|
|
|
Shoucheng Joins World Humanoid Robot Games - 88 Spectators Invited
Aug 13, 2025 22:33 HKT/SGT
|
|
|
MMG Announces 2025 Interim Results, Profit, Earnings and Cash up on Strong Copper Growth
Aug 13, 2025 22:31 HKT/SGT
|
|
|
Formerra Becomes North American Distributor for Syensqo PVDF
Aug 13, 2025 21:32 HKT/SGT
|
|
|
China Lilang Announces 2025 Interim Results
Aug 13, 2025 21:30 HKT/SGT
|
|
|
NMPA已受理亿胜生物关于EB12-20145P（HLX04-O）用于治疗湿性年龄相关性黄斑变性的生物制品许可申请
Aug 13, 2025 21:25 HKT/SGT
|
|
|
NMPA Accepted Essex's Biologics License Application for EB12-20145P (HLX04-O) for the Treatment of Wet Age-Related Macular Degeneration
Aug 13, 2025 21:24: JST
|
|
|
NMPA Accepted Essex's Biologics License Application for EB12-20145P (HLX04-O) for the Treatment of Wet Age-Related Macular Degeneration
Aug 13, 2025 20:24 HKT/SGT
|
|
|
NMPA已受理億勝生物關於EB12-20145P（HLX04-O）用於治療濕性年齡相關性黃斑變性的生物製品許可申請
Aug 13, 2025 20:24 HKT/SGT
|
|
|
潼關黃金獲納入MSCI全球小型股指數 資本市場影響力進一步提升
Aug 13, 2025 19:19 HKT/SGT
|
|
|
AsiaMedic Reports 26% Revenue Growth to S$16.6 million in 1H2025, Led by Strong Diagnostic Imaging Performance
Aug 13, 2025 14:00 HKT/SGT
|
|
|
74th China (Linyi) International Hardware Expo to Open September 5-7, 2025 in Shandong
Aug 13, 2025 13:00: JST
|
|
|
74th China (Linyi) International Hardware Expo to Open September 5-7, 2025 in Shandong
Aug 13, 2025 12:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
